Newsfeeds - Spark Newswire

1 minute read

35 Generic Drugmakers Sign To Manufacture Low-Cost Version Of Pfizer’s COVID Pill

Today, 9:11 PM

Thirty-five generic drugmakers will produce low-cost versions of Pfizer Inc’s (NYSE:PFE) COVID-19 pill, Paxlovid, to expand supplies of the highly effective drug…

PFE

1 minute read

FDA
News

FDA Approves First Generic Of Symbicort To Treat Asthma And COPD

By Benzinga Newsdesk

Today, 9:11 PM

-Reuters

VTRS

13 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For March 1, 2022

By Benzinga Insights

Today, 9:11 PM

Upgrades

ACLX

1 minute read

B of A Securities Downgrades Viatris to Neutral, Lowers Price Target to $13

By Benzinga Newsdesk

Today, 9:11 PM

B of A Securities analyst Jason Gerberry downgrades Viatris (NASDAQ:VTRS) from Buy to Neutral and lowers the price target from $21 to $13.

VTRS

1 minute read

Raymond James Downgrades Viatris to Market Perform

By Benzinga Newsdesk

Today, 9:11 PM

Raymond James analyst Elliot Wilbur downgrades Viatris (NASDAQ:VTRS) from Outperform to Market Perform.

VTRS

2 minute read

67 Biggest Movers From Yesterday

By Lisa Levin

Today, 9:11 PM

Losers

ADAG

1 minute read

Why Viatris Shares Are Trading Lower Today

By Adam Eckert

Today, 9:11 PM

Viatris Inc (NASDAQ: VTRS) is trading lower Monday after the company reported worse-than-expected top-line results for the fourth quarter and issued guidance below estimates.

PFE

3 minute read

42 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

Today, 9:11 PM

Gainers Mullen Automotive, Inc. (NASDAQ: MULN) jumped 74.4% to $1.20 after the company reported progress on solid-state polymer battery pack development.

AER

1 minute read

India-Based Biocon To Buy Viatris’ Biosimilars Assets In $3.3B Deal

By Vandana Singh

Today, 9:11 PM

Biocon Biologics Ltd has agreed to acquire Viatris Inc’s (NASDAQ:VTRS) biosimilars assets for up to $3.335 billion in stock and cash. The…

VTRS

1 minute read

Viatris: Q4 Earnings Insights

By Benzinga Insights

Today, 9:11 PM

Viatris (NASDAQ:VTRS) reported its Q4 earnings results on Monday, February 28, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

VTRS